Aurora to Present at Goldman Sachs Communacopia + Technology Conference
Aurora to Present at Goldman Sachs Communacopia + Technology Conference
Aurora Innovation, Inc. (NASDAQ: AUR) today announced Chris Urmson, CEO & Co-founder, will participate in a fireside chat at the Goldman Sachs Communacopia + Technology Conference on September 10, 2024 at 9:30 am Pacific Time.
The presentation will be webcast on Aurora’s investor relations website at ir.aurora.tech. A replay of the webcast will be available for 30 days following the live presentation.
About Aurora
Aurora (Nasdaq: AUR) is delivering the benefits of self-driving technology safely, quickly, and broadly to make transportation safer, increasingly accessible, and more reliable and efficient than ever before. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles, and underpins Aurora’s driver-as-a-service products for trucking and ride-hailing. Aurora is working with industry leaders across the transportation ecosystem, including Continental, FedEx, Hirschbach, PACCAR, Ryder, Schneider, Toyota, Uber, Uber Freight, Volvo Trucks, Volvo Autonomous Solutions, and Werner. To learn more, visit aurora.tech.
Aurora Overview
Aurora Press Kit
Investor Relations:
Stacy Feit
ir@aurora.tech
Media:
press@aurora.tech
View source version on businesswire.com: https://www.businesswire.com/news/home/20240827681353/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks